Skip to main content
Clinical Trials/NCT02092883
NCT02092883
Completed
Phase 4

Neuroinflammation in Children With Infantile Spasms Measured With 11C-PK11195 Positron Emission Tomography: Response to ACTH

Wayne State University1 site in 1 country8 target enrollmentMarch 2013
InterventionsACTH
DrugsACTH

Overview

Phase
Phase 4
Intervention
ACTH
Conditions
Infantile Spasms
Sponsor
Wayne State University
Enrollment
8
Locations
1
Primary Endpoint
Neuroinflammation in cortical and/or subcortical structures
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study was to investigate the presence of neuroinflammation in children with infantile spasms using 11C-PK11195 positron emission tomography (PK PET) scan, and its response to ACTH treatment by repeating the PK PET scan after treatment.

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
July 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Harry T Chugani

Professor

Wayne State University

Eligibility Criteria

Inclusion Criteria

  • A clinical diagnosis of 'cryptogenic IS'
  • Normal MRI
  • No other neurological disorder

Exclusion Criteria

  • Abnormal MRI
  • No anti-inflammatory medication 48 hrs prior to PK PET scans
  • Parent/guardian unable to give written consent

Arms & Interventions

Infantile Spasms

Intervention: ACTH

Outcomes

Primary Outcomes

Neuroinflammation in cortical and/or subcortical structures

Time Frame: up to 6 weeks

Neuroinflammation in cortical and/or subcortical structures of the brain in patients with Infantile Spasms will be evaluated with 11-C-PK11195 PET scan at the baseline and 2 weeks after the completion of ACTH treatment (given over 4 weeks), i.e., 6 weeks after the baseline PET scan.

Study Sites (1)

Loading locations...

Similar Trials